Better Quality of Life for People Living with Diabetes Through Validated Innovative Artificial Intelligence Applications
About Melissa
The MELISSA project aims to transform diabetes management for individuals with insulin-treated diabetes. By leveraging an Artificial Intelligence-based digital solution, MELISSA is designed to deliver personalized, efficient, and cost-effective care, adapting to each patient's unique needs, habits, and health progression. This approach promises to enhance the quality of life for millions by providing tailored support and improving clinical outcomes.
The necessity for MELISSA arises from the global surge in diabetes cases – 60 million people in Europe currently live with diabetes, and 36 million more are at high risk. By 2030, it is projected that over 10% of Europe’s population could be affected, posing severe consequences for individuals and the healthcare system alike. MELISSA’s AI-based solution could save 400,000 lives and reduce healthcare costs by €200 billion annually, marking a pivotal advancement in diabetes management.

1 June 2022

4 Years

approx. 8 Mil. €

7 Countries